Proteome Sciences (LON:PRM) Trading Up 0.6% – Still a Buy?

Proteome Sciences plc (LON:PRM) shares shot up 0.6% on Monday . The stock traded as high as GBX 2.30 and last traded at GBX 1.41. 248,823 shares changed hands during trading, a decline of 46% from the average session volume of 464,412 shares. The stock had previously closed at GBX 1.40.

Proteome Sciences Price Performance

The firm has a 50-day simple moving average of GBX 1.56 and a two-hundred day simple moving average of GBX 1.93. The company has a market capitalization of £8.00 million, a price-to-earnings ratio of -2.19 and a beta of 0.07. The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46.

Proteome Sciences (LON:PRM) last announced its quarterly earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.The company had revenue of GBX 376 million for the quarter.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.